Both semaglutide and tirzepatide have been approved by major regulatory authorities following extensive clinical research
GLP-1s may not eliminate desire altogether, but they seem to weaken the reinforcing loop between anticipation and consumption, making it easier for patients to pause, reflect, and make healthier choices." Dr Sophie Dix, Head of Medical Product and Content at Levity "We hear all the time that our patients on GLP-1 medications have spontaneously reported drinking less, smoking less, or simply losing interest in previously compulsive behaviors
For this analysis, full CGM data was available for 154 meals: 50 E1, 51 E2 and 53 E3
Novo Nordisk's semaglutide was found to reduce body weight, on average, by around 15%, or about 34 pounds, after 68 weeks
The workbook points you to the potential causes of high histamine in your life